Paul Brannelly Insider Trading $COLL COLLEGIUM PHARMACEUTICAL, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Brannelly.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Brannelly. Paul Brannelly is Executive Vice President & CFO in COLLEGIUM PHARMACEUTICAL, INC ($COLL).
Paul Brannelly in COLLEGIUM PHARMACEUTICAL, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Brannelly: Executive Vice President & CFO
Holdings: 215,758 shares
Current Value: $3,314,043
Latest Transaction: Jan 21 2021
$COLL Market Capitalization: $351.67M
$COLL Previous Close: $15.36
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul Brannelly in COLLEGIUM PHARMACEUTICAL, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 24.06 | 120,000 | 2,887,200 | 120,000 | |
| Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 8,161 | 0 | 223,919 | 215.8 K to 223.9 K (+3.78 %) |
| Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 42,000 | 0 | 215,758 | 173.8 K to 215.8 K (+24.17 %) |
| Aug 12 2020 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 18.89 | 1,515 | 28,618 | 173,758 | 175.3 K to 173.8 K (-0.86 %) |
| Feb 12 2020 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 21.62 | 4,025 | 87,021 | 175,273 | 179.3 K to 175.3 K (-2.24 %) |
| Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 21.56 | 214 | 4,614 | 151,173 | 151.4 K to 151.2 K (-0.14 %) |
| Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 11.24 | 1,517 | 17,051 | 151,387 | 152.9 K to 151.4 K (-0.99 %) |
| Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 9.04 | 797 | 7,205 | 152,904 | 152.1 K to 152.9 K (+0.52 %) |
| Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 11.24 | 1,517 | 17,051 | 151,387 | 152.9 K to 151.4 K (-0.99 %) |
| Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 9.04 | 797 | 7,205 | 152,904 | 152.1 K to 152.9 K (+0.52 %) |
| Jul 23 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 10.35 | 181 | 1,873 | 152,107 | 152.3 K to 152.1 K (-0.12 %) |
| Feb 11 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 14.39 | 2,693 | 38,752 | 152,288 | 155 K to 152.3 K (-1.74 %) |
| Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 15.90 | 32,000 | 508,800 | 32,000 | |
| Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 32,000 | 0 | 154,981 | 123 K to 155 K (+26.02 %) |
| Jan 23 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 15.76 | 214 | 3,373 | 122,981 | 123.2 K to 123 K (-0.17 %) |
| Aug 27 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 18.03 | 599 | 10,800 | 123,195 | 123.8 K to 123.2 K (-0.48 %) |
| Aug 06 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 20.15 | 181 | 3,647 | 123,794 | 124 K to 123.8 K (-0.15 %) |
| Aug 06 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.84 | 539 | 8,538 | 123,975 | 123.4 K to 124 K (+0.44 %) |
| Jun 22 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Sell | S | 28.35 | 4,900 | 138,915 | 123,436 | 128.3 K to 123.4 K (-3.82 %) |
| Jun 22 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Sell | S | 27.50 | 5,100 | 140,250 | 128,336 | 133.4 K to 128.3 K (-3.82 %) |
| Mar 01 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 21.77 | 1,197 | 26,059 | 133,436 | 134.6 K to 133.4 K (-0.89 %) |
| Feb 06 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 23.38 | 214 | 5,003 | 134,633 | 134.8 K to 134.6 K (-0.16 %) |
| Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 24.35 | 50,000 | 1,217,500 | 50,000 | |
| Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 10.17 | 1,044 | 10,617 | 134,847 | 133.8 K to 134.8 K (+0.78 %) |
| Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 25,000 | 0 | 133,803 | 108.8 K to 133.8 K (+22.98 %) |
| Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Gift | G | 0.00 | 2,000 | 0 | 108,803 | 110.8 K to 108.8 K (-1.81 %) |
| Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 12.39 | 200 | 2,478 | 110,803 | 111 K to 110.8 K (-0.18 %) |
| Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 10.60 | 776 | 8,226 | 111,003 | 110.2 K to 111 K (+0.70 %) |
| May 15 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Buy | P | 9.18 | 10,000 | 91,800 | 110,227 | 100.2 K to 110.2 K (+9.98 %) |
| Mar 21 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 14.95 | 388 | 5,801 | 100,227 | 100.6 K to 100.2 K (-0.39 %) |
| Aug 03 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 10.31 | 983 | 10,135 | 83,359 | 82.4 K to 83.4 K (+1.19 %) |
| May 23 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 16.89 | 1,100 | 18,579 | 82,376 | 81.3 K to 82.4 K (+1.35 %) |
| May 19 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 16.00 | 900 | 14,400 | 81,276 | 80.4 K to 81.3 K (+1.12 %) |
| May 18 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.46 | 1,000 | 15,460 | 80,376 | 79.4 K to 80.4 K (+1.26 %) |
| May 16 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.73 | 800 | 12,584 | 79,376 | 78.6 K to 79.4 K (+1.02 %) |
| May 13 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.02 | 1,200 | 18,024 | 78,576 | 77.4 K to 78.6 K (+1.55 %) |
| Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 16.15 | 29,475 | 476,021 | 29,475 | |
| Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 4,913 | 0 | 77,376 | 72.5 K to 77.4 K (+6.78 %) |
| May 18 2015 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 14.90 | 22,929 | 341,642 | 22,929 |
Page: 1